NASDAQ:OFIX - Orthofix Medical Stock Price, Forecast & News

Orthofix Medical trades on the NASDAQ under the ticker symbol "OFIX."

Orthofix Medical Inc (NASDAQ:OFIX) released its quarterly earnings results on Monday, October, 28th. The medical device company reported $0.41 EPS for the quarter, missing the Thomson Reuters' consensus estimate of $0.51 by $0.10. The medical device company had revenue of $113.50 million for the quarter, compared to the consensus estimate of $117.83 million. Orthofix Medical had a negative net margin of 6.81% and a positive return on equity of 9.16%. Orthofix Medical's revenue for the quarter was up 1.6% compared to the same quarter last year. During the same period last year, the company earned $0.44 earnings per share. View Orthofix Medical's Earnings History.

Orthofix Medical is scheduled to release their next quarterly earnings announcement on Monday, February 24th 2020. View Earnings Estimates for Orthofix Medical.

Orthofix Medical will be holding an earnings conference call on Monday, February 24th at 12:00 AM Eastern. Interested parties can register for or listen to the call using this link or dial in at Not Available.

2 brokers have issued twelve-month price targets for Orthofix Medical's shares. Their forecasts range from $48.00 to $48.00. On average, they expect Orthofix Medical's stock price to reach $48.00 in the next twelve months. This suggests a possible upside of 6.6% from the stock's current price. View Analyst Price Targets for Orthofix Medical.

2 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Orthofix Medical in the last year. There are currently 2 hold ratings for the stock, resulting in a consensus recommendation of "Hold." View Analyst Ratings for Orthofix Medical.

Media stories about OFIX stock have trended very negative on Saturday, according to InfoTrie Sentiment. InfoTrie identifies positive and negative press coverage by reviewing more than six thousand blog and news sources. The firm ranks coverage of publicly-traded companies on a scale of -5 to 5, with scores closest to five being the most favorable. Orthofix Medical earned a media sentiment score of -3.5 on InfoTrie's scale. They also gave press coverage about the medical device company a news buzz of 10.0 out of 10, meaning that recent press coverage is extremely likely to have an effect on the company's share price in the next few days. View News Stories for Orthofix Medical.

Orthofix Medical saw a decrease in short interest in January. As of January 31st, there was short interest totalling 316,400 shares, a decrease of 14.9% from the January 15th total of 371,800 shares. Based on an average daily volume of 146,900 shares, the short-interest ratio is currently 2.2 days. Currently, 1.7% of the company's stock are sold short. View Orthofix Medical's Current Options Chain.

Some companies that are related to Orthofix Medical include Abbott Laboratories (ABT), Medtronic (MDT), Stryker (SYK), Intuitive Surgical (ISRG), Becton Dickinson and (BDX), Boston Scientific (BSX), Edwards Lifesciences (EW), Baxter International (BAX), DexCom (DXCM), ResMed (RMD), IDEXX Laboratories (IDXX), Teleflex (TFX), Steris (STE), Hologic (HOLX) and Insulet (PODD).

Based on aggregate information from My MarketBeat watchlists, some companies that other Orthofix Medical investors own include AbbVie (ABBV), Enterprise Products Partners (EPD), Exxon Mobil (XOM), Clovis Oncology (CLVS), Esperion Therapeutics (ESPR), Gilead Sciences (GILD), iCAD (ICAD), Intercept Pharmaceuticals (ICPT), Madrigal Pharmaceuticals (MDGL) and Zogenix (ZGNX).

Orthofix Medical's stock is owned by a variety of of institutional and retail investors. Top institutional shareholders include Paradice Investment Management LLC (4.36%), State Street Corp (3.59%), Goldman Sachs Group Inc. (2.64%), Dalton Greiner Hartman Maher & Co. (2.23%), Renaissance Technologies LLC (1.94%) and Geode Capital Management LLC (1.65%). Company insiders that own Orthofix Medical stock include Brad Mason, Bradley V Niemann, Davide Bianchi, Kimberley A Elting, Luke T Faulstick, Rice Doug and Ronald A Matricaria. View Institutional Ownership Trends for Orthofix Medical.

OFIX stock was sold by a variety of institutional investors in the last quarter, including Victory Capital Management Inc., Victory Capital Management Inc., Marshall Wace LLP, Mackay Shields LLC, AJO LP, Renaissance Technologies LLC, SG Americas Securities LLC and Geode Capital Management LLC. View Insider Buying and Selling for Orthofix Medical.

OFIX stock was acquired by a variety of institutional investors in the last quarter, including Royce & Associates LP, Dalton Greiner Hartman Maher & Co., Bank of Montreal Can, Jacobs Levy Equity Management Inc., Great West Life Assurance Co. Can, Thrivent Financial for Lutherans, Paradice Investment Management LLC and Charles Schwab Investment Management Inc.. View Insider Buying and Selling for Orthofix Medical.

Shares of OFIX can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

One share of OFIX stock can currently be purchased for approximately $45.04.

Orthofix Medical has a market capitalization of $858.46 million and generates $453.04 million in revenue each year. The medical device company earns $13.81 million in net income (profit) each year or $1.96 on an earnings per share basis. Orthofix Medical employs 954 workers across the globe.View Additional Information About Orthofix Medical.

The official website for Orthofix Medical is http://www.orthofix.com/.

Orthofix Medical's mailing address is 3451 Plano Parkway, Lewisville TX, 75056. The medical device company can be reached via phone at 214-937-2000 or via email at [email protected]